Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-06
2009-06-23
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S340000
Reexamination Certificate
active
07550475
ABSTRACT:
The present invention provides a novel a condensed polycyclic compound useful as a phosphodiesterase 4 inhibitor, which is shown by the formula [I]:or a pharmaceutically acceptable salt thereof and a pharmaceutical composition containing the same.
REFERENCES:
patent: 4678501 (1987-07-01), Manning
patent: 6005106 (1999-12-01), Ukita et al.
patent: 6011060 (2000-01-01), Laurent et al.
patent: 0 557 016 (1993-08-01), None
patent: 0 748 805 (1996-12-01), None
patent: 2000-063275 (2000-02-01), None
patent: WO 97/22585 (1997-06-01), None
patent: WO 97/23457 (1997-07-01), None
patent: WO 98/02440 (1998-01-01), None
patent: WO 98/09961 (1998-03-01), None
patent: WO 98/14432 (1998-04-01), None
patent: WO 00/12503 (2000-03-01), None
patent: WO 02/00657 (2002-01-01), None
patent: WO 02/38563 (2002-05-01), None
patent: WO 02/094320 (2002-11-01), None
patent: WO 02/094321 (2002-11-01), None
Dyke et al. Expert Opin. Investig.Drugs, vol. 11(1), p. 1-13 (2002).
Huang et al. Current Opinion in Chemical Biology, vol. 5, p. 432-438 (2001).
Baumer et al. Inflammation & Allergy-Drug Targets vol. 6, p. 17-26 (2006).
Dal Piaz et al. Eur. J.Med.Chem. vol. 35, p. 463-480 (2000).
Dyke et al. Exp.Opin.Invest.Drugs, vol. 8(9), p. 1301-1325 (1999).
Aril K. Saxena et al., “Compounds Acting on the CNS: Part XXI—Synthesis of a 2-Substituted 1,3,4,6,II,IIa-Hexahydro-2(H)pyrazino, etc.,”Indian Journal of Chemistry, vol. 13, Mar. 1975, pp. 230-237.
J. Mol Cell Cardiol, vol. 21 (Supplement II) (1989), S.61.
Nakata Aya
Ogawa Koji
Sakai Atsuko
Terakawa Yoshihiro
Ukita Tatsuzo
Bernhardt Emily
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Mitsubishi Tanabe Pharma Corporation
LandOfFree
Condensed polycyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Condensed polycyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Condensed polycyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4082792